Cipher Pharmaceuticals Schedules Q3 2020 Earnings Release and Conference Call

November 3, 2020 |

1 min read

Cipher Pharmaceuticals Inc. (TSX: CPH) (“Cipher” or “the Company”) today announced it will release its Q3 2020 financial results after the close on Thursday, November 12, 2020.

OAKVILLE, ON, Nov. 3, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (“Cipher” or “the Company”) today announced it will release its Q3 2020 financial results after the close on Thursday, November 12, 2020. The Company will hold a conference call on Friday, November 13, 2020 to discuss the results.

CONFERENCE CALL DETAILS

DATE:	Friday, November 13, 2020
TIME:	8:30 a.m ET
DIAL-IN:	(416) 764-8688 or (888) 390-0546
CONFERENCE ID:	46246305
REPLAY DIAL-IN:	1 (888) 390-0541 (Playback 246305 #)
Expires November 20, 2020
Webcast: https://produceredition.webcasts.com/starthere.jsp?ei=1397006&tp_key=a8d3b9b5c2

About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.

SOURCE Cipher Pharmaceuticals Inc.

Company Codes: OtherOTC:CPHRF, Toronto:CPH

Earnings